⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SXTP News
60 Degrees Pharmaceuticals, Inc. Common Stock
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
globenewswire.com
SXTP
Form 8-K
sec.gov
SXTPW
SXTP
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
globenewswire.com
SXTP
Form 8-K
sec.gov
SXTPW
SXTP
CERO
SCYX
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
globenewswire.com
SXTP
RedChip's Biotech Investor Conference Replays Now Available
accessnewswire.com
SXTP
BIVI
BFRG
LTRN
NXL
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
globenewswire.com
SXTPW
SXTP
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
accessnewswire.com
SXTP
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
accessnewswire.com
SXTP
BIVI
BFRG
LTRN
NXL
60 Degrees Pharmaceuticals Announces 2025 Annual Results
globenewswire.com
SXTPW
SXTP